Overuse injuries

Tendinopathy Epidemiology Forecast Research Report 2021-2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 28, 2021

The "Tendinopathy - Epidemiology Forecast to 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Tendinopathy - Epidemiology Forecast to 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This 'Tendinopathy - Epidemiology Forecast-2030' report delivers an in-depth understanding of Tendinopathy, historical and forecasted epidemiology as well as the Tendinopathy trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
  • In 2020, the total incident cases of Tendinopathy were found out to be 29,282,773 in the 7MM.
  • The report provides the segmentation of the disease epidemiology for 7MM by Total Incident Cases of Tendinopathy, Gender-specific Incident Cases of Tendinopathy, Type-specific Incident Cases of Tendinopathy, and Region-specific Incident Cases of Tendinopathy.

Studies Show Sustained Acoustic Medicine Effectively Treats Shoulder Injuries

Retrieved on: 
Tuesday, July 27, 2021

TRUMBULL, Conn., Jul 27, 2021 /PRNewswire/ --Two recently published studies found that the long-duration, wearable sustained acoustic medicine device from ZetrOZ Systems relieves pain from shoulder and other injuries when conservative therapies fail, and can be a replacement for pain medications.

Key Points: 
  • TRUMBULL, Conn., Jul 27, 2021 /PRNewswire/ --Two recently published studies found that the long-duration, wearable sustained acoustic medicine device from ZetrOZ Systems relieves pain from shoulder and other injuries when conservative therapies fail, and can be a replacement for pain medications.
  • "Sustained acoustic medicine gives doctors an additional way to treat musculoskeletal injuries and to treat post-operative pain, and avoid potentially addictive pain medications."
  • Sustained acoustic medicine provides an attractive home-use treatment option for patients suffering from upper trapezius myofascial pain."
  • The authorsconcluded that sustained acoustic medicine showed promise as a "self-applied effective therapy, and as a possible replacement or adjuvant to pharmacotherapies for shoulder pain."

Study shows Smith+Nephew's REGENETEN™ Bioinductive Implant sets new standard of recovery for partial-thickness rotator cuff tears

Retrieved on: 
Wednesday, July 21, 2021

Smith+Nephew's REGENETEN Bioinductive Implant is available in the US, Europe and other select countries worldwide.

Key Points: 
  • Smith+Nephew's REGENETEN Bioinductive Implant is available in the US, Europe and other select countries worldwide.
  • Treatment of partial-thickness rotator cuff tear repairs with a resorbable bioinductive bovine collagen implant: 1-year results from a prospective multi-center registry.
  • Evidence of healing of partial-thickness rotator cuff tears following arthroscopic augmentation with a collagen implant: a 2-year MRI follow-up.
  • Healing of partial-thickness rotator cuff tears following arthroscopic augmentation with a highly porous collagen implant: a 5-year clinical and MRI follow-up.

Study shows Smith+Nephew's REGENETEN◊ Bioinductive Implant sets new standard of recovery for partial-thickness rotator cuff tears

Retrieved on: 
Wednesday, July 21, 2021

Smith+Nephew's REGENETEN Bioinductive Implant is available in the US, Europe and other select countries worldwide.

Key Points: 
  • Smith+Nephew's REGENETEN Bioinductive Implant is available in the US, Europe and other select countries worldwide.
  • Treatment of partial-thickness rotator cuff tear repairs with a resorbable bioinductive bovine collagen implant: 1-year results from a prospective multi-center registry.
  • Evidence of healing of partial-thickness rotator cuff tears following arthroscopic augmentation with a collagen implant: a 2-year MRI follow-up.
  • Healing of partial-thickness rotator cuff tears following arthroscopic augmentation with a highly porous collagen implant: a 5-year clinical and MRI follow-up.

Stryker announces the FDA clearance of the first biodegradable subacromial balloon spacer, filling a gap in the shoulder continuum of care

Retrieved on: 
Tuesday, July 13, 2021

KALAMAZOO, Mich., July 13, 2021 /PRNewswire/ -- Stryker announced today the FDA clearance of the first balloon implant for arthroscopic treatment of massive irreparable rotator cuff tears (MIRCTs)*.

Key Points: 
  • KALAMAZOO, Mich., July 13, 2021 /PRNewswire/ -- Stryker announced today the FDA clearance of the first balloon implant for arthroscopic treatment of massive irreparable rotator cuff tears (MIRCTs)*.
  • InSpace provides a new option for surgeons in their shoulder continuum of care that allows them to better meet the needs of their patients.
  • This ground-breaking technology was acquired from OrthoSpace, Ltd. in 2019 and is the first of its kind in the U.S. market.
  • The InSpace balloon implant is designed to restore the subacromial space without requiring sutures or fixation devices and has been demonstrated to improve shoulder motion and function.

Chicago Marathon Physician Offers Tips to Avoid Common Running Injuries

Retrieved on: 
Thursday, July 1, 2021

Injuries are very common among runners.Recent research estimates that 82% of runners will become injured during their running careerand up to 90% will experience injury while training for a marathon.

Key Points: 
  • Injuries are very common among runners.Recent research estimates that 82% of runners will become injured during their running careerand up to 90% will experience injury while training for a marathon.
  • Some of the most common include a stress fracture, plantar fasciitis, hamstring tendinitis, ankle sprain, runners' knee, and Achilles' tendonitis.
  • Here are some safety tips from Dr. Joshua Blomgren , a 15-time Chicago Marathon team physician and sports medicine physician, Midwest Orthopaedics at Rush :
    Don't increase weekly mileage or intensity by more than 10 percent each week.
  • If you would like to talk with Dr. Joshua Blomgren about your running injury, please visit www.rushortho.com or call 877.MD.BONES.

Stā Active and USPTA announce a multi-year partnership to introduce the Fiix Elbow product to the tennis marketplace and to educate teaching professionals and players on the benefits of instrument-assisted soft tissue mobilization (IASTM)

Retrieved on: 
Thursday, May 20, 2021

"\n"The Fiix Elbow is the ultimate in-home tennis elbow treatment solution," says John Embree, USPTA CEO.

Key Points: 
  • "\n"The Fiix Elbow is the ultimate in-home tennis elbow treatment solution," says John Embree, USPTA CEO.
  • The fact that St Active offers a moneyback guarantee to reduce elbow pain should convince players and USPTA members alike to try the Fiix Elbow product.
  • "\n"We\'re ecstatic to partner with the USPTA and their tennis-teaching professionals," says St Active Co-founder and President Tim Porth.
  • "With an automated proven physical therapy technique 96 percent of study subjects reported reduced pain after using the Fiix Elbow.

Global Joint Pain Injection Market (2021 to 2028) - COVID-19 Impact and Analysis - ResearchAndMarkets.com

Retrieved on: 
Friday, May 14, 2021

However, the high costs of joint repair therapies hinder the market growth.\nHyaluronic acid injections are usually administered for treating sports injuries, as they aid in pain relief, reduce inflammation, and improve joint function.

Key Points: 
  • However, the high costs of joint repair therapies hinder the market growth.\nHyaluronic acid injections are usually administered for treating sports injuries, as they aid in pain relief, reduce inflammation, and improve joint function.
  • Sports injuries are caused due to direct impact or due to the application of force that is larger than the body part can withstand.
  • Thus, the growing number of sport injuries is boosting the demand for joint pain injections.\nBased on joint type, the joint pain injection market is segmented into knee, shoulder and elbow, hip, foot and ankle, and others.
  • In 2020, the knee joint type segment accounted for the largest share of the market.

HeelAid First Brush-On Treatment to Relieve Plantar Fasciitis Pain in a Week Now With CBD

Retrieved on: 
Thursday, March 25, 2021

"Cannabidiol, known as CBD, represents the biggest breakthrough in non-opioid pain relief in decades," continued Dr. Burke.

Key Points: 
  • "Cannabidiol, known as CBD, represents the biggest breakthrough in non-opioid pain relief in decades," continued Dr. Burke.
  • "We added CBD to the already impressive HeelAid formulation and have seen how the plantar fascia responds exquisitely to this safe, natural, pain relieving substance."
  • Based on ongoing clinical trials and patient data, pain relief usually occurs within a week for 3 out of 4 patients.
  • ABOUT HEELAID and BRIANT BURKE MD, MS
    HeelAid is the first brush-on natural, topical agent to provide pain relief within a week for the symptoms of plantar fasciitis.

Lateral epicondylitis treatment market featuring Cipla Inc. and Colfax Corp. among others |Technavio

Retrieved on: 
Tuesday, March 23, 2021

The lateral epicondylitis treatment market is driven by the rising awareness about lateral epicondylitis.

Key Points: 
  • The lateral epicondylitis treatment market is driven by the rising awareness about lateral epicondylitis.
  • In addition, the high incidence of sports injuries is anticipated to boost the growth of the lateral epicondylitis treatment market.
  • Hence, an increase in the number of organizations and institutes that raise awareness among people about lateral epicondylitis is expected to drive the growth of the global lateral epicondylitis treatment market during the forecast period.
  • Lateral Epicondylitis Treatment Market Type Outlook (Revenue, USD billion, 2020-2025)
    Lateral Epicondylitis Treatment Market Geography Outlook (Revenue, USD billion, 2020-2025)
    Are you a start-up willing to make it big in the business?